Vitamin Shoppe Inc (VSI)

26.00
0.45 1.76
NYSE : Services
Prev Close 25.55
Open 25.55
Day Low/High 25.40 / 26.15
52 Wk Low/High 21.90 / 34.41
Volume 237.32K
Avg Volume 238.40K
Exchange NYSE
Shares Outstanding 23.82M
Market Cap 600.18M
EPS 1.80
P/E Ratio 14.48
Div & Yield N.A. (N.A)

Latest News

Food Retailers Don't Look Very Tasty

Food Retailers Don't Look Very Tasty

Walmart is gaining traction, putting additional pressure on rival food retailers just as deflationary pressures mount, Barclays analysts say.

Food Retailers Don't Look Very Tasty

Food Retailers Don't Look Very Tasty

Sector faces price deflation and a tough challenge from Wal-Mart.

Vitamin Shoppe Reaches Analyst Target Price

Vitamin Shoppe Reaches Analyst Target Price

In recent trading, shares of Vitamin Shoppe Inc have crossed above the average analyst 12-month target price of $25.57, changing hands for $26.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Commit To Purchase Vitamin Shoppe At $20, Earn 10.9% Annualized Using Options

Commit To Purchase Vitamin Shoppe At $20, Earn 10.9% Annualized Using Options

Investors eyeing a purchase of Vitamin Shoppe Inc stock, but cautious about paying the going market price of $23.35/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $20 strike, which has a bid at the time of this writing of $1.15.

RSI Alert: Vitamin Shoppe (VSI) Now Oversold

RSI Alert: Vitamin Shoppe (VSI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Procter & Gamble Must Prove It's Hungry for Big Deals, Too

Procter & Gamble Must Prove It's Hungry for Big Deals, Too

After ridding itself of slower-growth beauty brands, Procter & Gamble must show its appetite for acquisitions.

Unilever Buying Jessica Alba's Honest Company Is Latest Old Company Trying to Find New Life

Unilever Buying Jessica Alba's Honest Company Is Latest Old Company Trying to Find New Life

Battling various industry shifts, big, old multinationals use acquisitions to tap into the fountain of youth.

Vitamin Shoppe, Inc. Announces International Expansion

Vitamin Shoppe, Inc. Announces International Expansion

- First Three Franchise Stores Open In Costa Rica

Vitamin Shoppe Enters Oversold Territory (VSI)

Vitamin Shoppe Enters Oversold Territory (VSI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

GNC Goes South After C-Suite Shake-Up

GNC Goes South After C-Suite Shake-Up

Shares in the retailer of nutritional supplements plummet on Thursday as it announces the departure of CEO Archbold after a less than two-year-long turnaround attempt.

VSI Crosses Above Average Analyst Target

VSI Crosses Above Average Analyst Target

In recent trading, shares of Vitamin Shoppe Inc have crossed above the average analyst 12-month target price of $31.38, changing hands for $31.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Herbalife's Correct Price; What Bill Ackman Needs: Jim Cramer’s Best Blogs

Herbalife's Correct Price; What Bill Ackman Needs: Jim Cramer’s Best Blogs

Jim Cramer talks about the what Bill Ackman needs and how to figure out Herbalife's correct price.

Bill Ackman Just Can't Seem to Catch a Break With Regulators

Bill Ackman Just Can't Seem to Catch a Break With Regulators

Shares of Herbalife jumped on Friday on news that regulators have concluded the company is not what Ackman alleged -- an illicit pyramid scheme.

Jim Cramer -- What Should You Pay for Herbalife Now?

Jim Cramer -- What Should You Pay for Herbalife Now?

You need out-and-out war between hedge fund managers and a monster squeeze to justify these prices, Cramer says.

Ackman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing

Ackman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing

It looks like the billionaire activist can't catch a break on these two stocks.

Cramer: Only Herbalife's Earnings Power Shows You the Correct Price

Cramer: Only Herbalife's Earnings Power Shows You the Correct Price

Anything above that, you speculate on Ackman vs. Icahn.

Commit To Buy Vitamin Shoppe At $22.50, Earn 7.2% Annualized Using Options

Commit To Buy Vitamin Shoppe At $22.50, Earn 7.2% Annualized Using Options

Investors eyeing a purchase of Vitamin Shoppe Inc stock, but cautious about paying the going market price of $30.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $22.50 strike, which has a bid at the time of this writing of $1.00.

Why Shares Of 103-Year-Old Clorox Just Hit an All-Time High

Why Shares Of 103-Year-Old Clorox Just Hit an All-Time High

It all comes down to results.

"Commit To Fit" On May 14th With The Vitamin Shoppe®

All Stores Nationwide will Host a Share the Health Expo®

Clorox, Consumer Products Should Shine Amid Jobs Slowdown, Cramer Says

Clorox, Consumer Products Should Shine Amid Jobs Slowdown, Cramer Says

Procter & Gamble and Johnson & Johnson may also be good buys according to TheStreet's founded.

Stock To Watch: Vitamin Shoppe (VSI) In Perilous Reversal

Stock To Watch: Vitamin Shoppe (VSI) In Perilous Reversal

Trade-Ideas LLC identified Vitamin Shoppe (VSI) as a "perilous reversal" (up big yesterday but down big today) candidate

Clorox CEO: Why I Spent $295 Million for a Digestive Health Company

Clorox CEO: Why I Spent $295 Million for a Digestive Health Company

The consumer products giant's move into faster-growing health and wellness products continues to pay dividends.

Don't Be Tempted on the GNC Turnaround

The strategic alternative announcement is smoke and mirrors.